RxDoctor Payments Data

Lynn Colombo, MD

Family Medicine · Cranford, NJNPI 1871931204

Payments from drug & device makers

$2,976in general payments, 2019–2025

Across 184 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$850
  • Lilly USA, LLC$529
  • Exact Sciences$185
  • Boehringer Ingelheim$136
  • Abbott$134
  • Pfizer$118
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,976100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,976 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$298,226
Medicare patients
436
Services billed
2,877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$49,672
OzempicSemaglutide32$38,044
JardianceEmpagliflozin17$18,783
MounjaroTirzepatide11$11,569
LinzessLinaclotide11$6,021
GemtesaVibegron17$4,142
BelsomraSuvorexant22$3,780
Atorvastatin Calcium217$2,680
Amlodipine Besylate187$1,462
Levothyroxine Sodium116$1,356
Gabapentin83$1,260
Rosuvastatin Calcium80$1,213
Mirtazapine46$1,164
Losartan Potassium85$1,121
Quetiapine Fumarate52$1,076

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$118$49,67265 claims
Novo NordiskOzempic$850$38,04432 claims
Boehringer IngelheimJardiance$136$18,78317 claims
Lilly USA, LLCMounjaro$529$11,56911 claims
AbbVieLinzess, Synthroid$75$7,03332 claims
MerckBelsomra$114$3,78022 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Cranford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →